News Articles Tagged: First-Line Therapy

The Evolving Role of Panitumumab in First-Line mCRC Treatment

Exploring the latest clinical evidence on Panitumumab's efficacy as a first-line therapy for metastatic colorectal cancer, including comparisons with other targeted agents. From NINGBO INNO PHARMCHEM CO.,LTD.

Lorlatinib in First-Line ALK-Positive NSCLC: Efficacy and Patient Selection

NINGBO INNO PHARMCHEM CO.,LTD. examines the efficacy of Lorlatinib as a first-line treatment for ALK-positive NSCLC, discussing patient selection criteria and outcomes.